Hjem › Immunsystem og lidelser › Florida
Immunsystem og lidelser kliniske forsøg i Florida
11 studier for Immunsystem og lidelser søger deltagere på steder i Florida.
Byer i Florida
Officiel studietekst (engelsk)
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- Moffit Cancer Center, Tampa
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07192471A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
- Jade Clinical Site, Orlando
- Jade Clinical Site, Pembroke Pines
RekruttererFase 2
Alder 18 til 60 · Alle køn · Opdateret 25. sep. 2026 · NCT07541287Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
- Holy Cross Hospital, Fort Lauderdale
- Mayo Clinic in Florida, Jacksonville
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 17. sep. 2026 · NCT04242095PS-002 for the Treatment of IgA Nephropathy in Adults
- University of Miami Hospital, Miami
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07182227A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
- AllerVie Clinical Research, Panama City
- GCP Research , Global Clinical Professionals, St. Petersburg
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT07765888A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
- Moffitt Cancer Center, Tampa
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 28. aug. 2026 · NCT07075185Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
- Nephrology Associates Of Central FL, Orlando
RekruttererFase 3
Alder 18 til 100 · Alle køn · Opdateret 17. aug. 2026 · NCT06858319A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 19, Ocala
- Inmagene Site 4, Tampa
RekruttererFase 2
Alder 18 til 74 · Alle køn · Opdateret 12. aug. 2026 · NCT07037901Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Moffitt Cancer Center, Tampa
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 7. jul. 2026 · NCT07216443CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Mayo Clinic, Jacksonville
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 16. apr. 2026 · NCT03328078A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- AdventHealth Orlando, Orlando
- Moffitt Cancer Center, Tampa
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 15. dec. 2025 · NCT06619561Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.